| [1] |
YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan.
Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923.
|
| [2] |
LEI Jianlin, WANG Na, WANG Wenzheng, WANG Yan.
One Case of Phenytoin Intoxication Caused by Compound Phenytoin Sodium Ephedrine Hydrochloride and Theophylline Tablets
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 819-822.
|
| [3] |
XIE Ziyue, WANG Chengxiang, HU Yanpeng, LI Lei, CUI Herong.
Clinical Medications and Safety Analysis of Traditional Chinese Medicine for Post-Infection Cough
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 507-512.
|
| [4] |
SHAO Bo, ZHONG Lumiao, CHENG Yuzhu, DENG Hua, ZHU Lan.
Risks to Safety of Yinhuang Oral Preparation
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 84-87.
|
| [5] |
CAO Ying, ZHOU Huziwei, ZHU Lan, WANG Shengfeng.
Management of compound glycyrrhiza oral solution and recommendations
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 529-534.
|
| [6] |
CHEN Bing, YUAN Dezheng, FU Yi.
Effect of Tianlongjie stage interventions on lung tissue remodeling and lung function of pulmonary fibrosis rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 540-546.
|
| [7] |
CHEN Bing, YUAN Dezheng, FU Yi.
Tianlongjie stage intervention on TGF-β1 level and pathological changes in lung tissue of pulmonary fibrosis rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 319-323.
|
| [8] |
LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong.
One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
|
| [9] |
WANG Guohua, LI Xiaolei, LIU Xiping, DONG Yizhi, ZANG Chen, XU Hong, TIAN Jixiang, ZHAO Jing.
Aerosol inhalation of Tanreqing injection in the treatment of chronic obstructive pulmonary disease: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 544-552.
|
| [10] |
BAO Lei, GENG Zihan, GUO Shanshan, YAO Rongmei, SUN Jing, CUI Xiaolan.
Effect of Reyanning Heji on animal models of respiratory infectious inflammation
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 241-247.
|
| [11] |
WANG Dan, WU Chen, REN Jingtian.
Risk analysis of dextromethorphan abuse
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1097-1099.
|
| [12] |
ZHU Na, KAN Xiaohong, WU Xinli, DING Haihua, XUE Shuya, ZHANG Yunling.
113 reports of adverse drug reactions induced by fluoroquinolones in patients with tuberculosis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 404-407.
|
| [13] |
SU Xinxin, LI Lixun, WANG Zhifei, XIE Yanming, WANG Qi.
Real-world study on Xiyanping injection combined in the treatment of childhood pneumonia
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 47-51.
|
| [14] |
ZHANG Tingyu, GE Ziruo, QIAN Fang, SONG Meihua, LI Xingang, TIAN Di, XU Yanli, CHEN Zhihai, ZHANG Wei.
Clinical Effect of Continuous High-dose Convalescent Plasma Therapy for Rapidly Progressing COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 801-805.
|
| [15] |
WANG Yaxin, CUI Xiaolan, GUO Shanshan.
Research Progress on Prevention and Treatment of Respiratory Virus Infectious Diseases with Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(6): 592-596.
|
